CMS Takes Action to Protect Integrity of Covid-19 Testing
The agency has issued cease-and-desist letters to laboratories conducting covid-19 testing without appropriate certification.
Read MorePosted by Melanie Hamilton-Basich | Oct 9, 2020 | Covid 19, Standards |
The agency has issued cease-and-desist letters to laboratories conducting covid-19 testing without appropriate certification.
Read MorePosted by Melanie Hamilton-Basich | Oct 7, 2020 | Covid 19, Molecular Diagnostics |
LabCorp’s new, high-throughput method uses heat and technology to extract RNA from samples collected for covid-19 molecular testing.
Read MorePosted by Melanie Hamilton-Basich | Oct 7, 2020 | Covid 19, Immunoassay Reagents & test Kits |
The novel kit combines a liquid-based sample preparation step completed in 2 minutes with real-time PCR detection in a streamlined workflow.
Read MorePosted by Melanie Hamilton-Basich | Oct 7, 2020 | Hematology & Serology |
DiaSorin is now able to offer a complete testing solution for Hepatitis A, Hepatitis B, and Hepatitis C in the United States.
Read MorePosted by Laurie Bonner | Oct 6, 2020 | Company News, Covid 19 |
The addition of new, rapid point-of-care platforms will expand national testing options.
Read More